World's Best Scientists 2026 revealed!

D-Index & Metrics

Chemistry

D-Index
44
Citations
6653
World Ranking
16914
National Ranking
4177

Overview

Richard G. Ball is affiliated with MSD in the United States. Their research primarily intersects the fields of Materials Science, with specific focus areas in Materials Chemistry, Cellular and Molecular Neuroscience, Molecular Biology, and Endocrinology, Diabetes and Metabolism.

The body of Ball's work explores multiple scientific topics, including:

  • Neuropeptides and Animal Physiology
  • Receptor Mechanisms and Signaling
  • Diabetes Treatment and Management
  • Crystallization and Solubility Studies
  • X-ray Diffraction in Crystallography

Richard G. Ball has contributed to scientific literature through publications in established venues such as Bioorganic & Medicinal Chemistry Letters and The Cambridge Structural Database. Notable papers include:

  • "Fragment-based lead discovery of a novel class of small molecule antagonists of neuropeptide B/W receptor subtype 1 (GPR7)" (2020), published in Bioorganic & Medicinal Chemistry Letters
  • "CCDC 2358644: Experimental Crystal Structure Determination" (2024), published in The Cambridge Structural Database

Their collaborations feature a number of frequent co-authors, indicating interdisciplinary and team-based research efforts. These co-authors include Remond Moningka, F. Anthony Romero, Nicholas B. Hastings, Zhiqiang Guo, and Ming Wang.

Best Publications

  • Isolation, structure, and absolute stereochemistry of platensimycin, a broad spectrum antibiotic discovered using an antisense differential sensitivity strategy.

    Sheo B Singh;Hiranthi Jayasuriya;John G Ondeyka;Kithsiri B Herath

  • Structure−Activity Relationship of Heterobase-Modified 2‘-C-Methyl Ribonucleosides as Inhibitors of Hepatitis C Virus RNA Replication

    Anne B Eldrup;Marija Prhavc;Jennifer Brooks;Balkrishen Bhat

  • Synthesis and structure of dicarbonylbis(.eta.-pentamethylcyclopentadienyl)diiridium

    Unknown

  • Nodulisporic Acid A, a Novel and Potent Insecticide from a Nodulisporium Sp. Isolation, Structure Determination, and Chemical Transformations

    John G. Ondeyka;Gregory L. Helms;Otto D. Hensens;Michael A. Goetz

  • Total Synthesis and Determination of the Absolute Configuration of Epibatidine

    Stephen R. Fletcher;Raymond Baker;Mark S. Chambers;Richard H. Herbert

  • Discovery of [(2R,5R)-5-{[(5-Fluoropyridin-2-yl)oxy]methyl}-2-methylpiperidin-1-yl][5-methyl-2-(pyrimidin-2-yl)phenyl]methanone (MK-6096): A Dual Orexin Receptor Antagonist with Potent Sleep-Promoting Properties

    Paul J. Coleman;John D. Schreier;Christopher D. Cox;Michael J. Breslin

  • Piperidine-ether based hNK1 antagonists 1: Determination of the relative and absolute stereochemical requirements

    T. Harrison;B.J. Williams;C.J. Swain;R.G. Ball

  • 3-Heteroaryl-2-pyridones: benzodiazepine site ligands with functional delectivity for alpha 2/alpha 3-subtypes of human GABA(A) receptor-ion channels

    Ian Collins;Christopher Moyes;William B Davey;Michael Rowley

  • A novel 3-substituted benzazepinone growth hormone secretagogue (L-692,429).

    William R. Schoen;Judith M. Pisano;Kristine Prendergast;Matthew J. Wyvratt

  • 1-(((7,7-Dimethyl-2(S)-(2(S)-amino-4-(methylsulfonyl)butyramido)bicyclo[2.2.1]heptan-1(S)-yl)methyl)sulfonyl)-4-(2-methylphenyl)piperazine (L-368,899): An Orally Bioavailable, Non-Peptide Oxytocin Antagonist with Potential Utility for Managing Preterm Labor

    Peter D. Williams;Paul S. Anderson;Richard G. Ball;Mark G. Bock

  • Aryl sulfones : A new class of γ-secretase inhibitors

    Martin Teall;Paul Oakley;Timothy Harrison;Duncan Shaw

  • Preussomerins and Deoxypreussomerins: Novel Inhibitors of Ras Farnesyl-Protein Transferase

    Sheo B. Singh;Deborah L. Zink;Jerrold M. Liesch;Richard G. Ball

  • Isolation and structure elucidation of parnafungins, antifungal natural products that inhibit mRNA polyadenylation.

    Craig A. Parish;Scott K. Smith;Kathleen Calati;Deborah Zink

  • Controlled modification of acidity in cholecystokinin B receptor antagonists: N-(1,4-benzodiazepin-3-yl)-N'-[3-(tetrazol-5-ylamino) phenyl]ureas.

    José L. Castro;Richard G. Ball;Howard B. Broughton;Michael G. N. Russell

  • Optimization of a tertiary alcohol series of phosphodiesterase-4 (PDE4) inhibitors: structure-activity relationship related to PDE4 inhibition and human ether-a-go-go related gene potassium channel binding affinity.

    Richard W Friesen;Yves Ducharme;Richard G Ball;Marc Blouin

  • Discovery of Vibegron: A Potent and Selective β3 Adrenergic Receptor Agonist for the Treatment of Overactive Bladder

    Scott D. Edmondson;Cheng Zhu;Nam Fung Kar;Jerry Di Salvo

  • Activation of dihydrogen by ruthenium(II)-chelating phosphine complexes, and activation of dioxygen by ruthenium(II) porphyrin complexes: an update

    Brian R. James;A. Pacheco;S.J. Rettig;I.S. Thorburn

  • Methoxylation of cocaine reduces binding affinity and produces compounds of differential binding and dopamine uptake inhibitory activity: discovery of a weak cocaine "antagonist"

    Daniele Simoni;Johannes Stoelwinder;Alan P. Kozikowski;Kenneth M. Johnson

  • Zaragozic acid A, a potent inhibitor of squalene synthase: initial chemistry and absolute stereochemistry

    Kenneth E. Wilson;Robert M. Burk;Tesfaye Biftu;Richard G. Ball

  • An Efficient Preparation of Vinamidinium Hexafluorophosphate Salts

    Ian W. Davies;Jean-Francois Marcoux;Jimmy Wu;Michael Palucki

  • Asymmetric Synthesis of α,α-Difluoro-β-amino Acid Derivatives from Enantiomerically Pure <i>N-tert-</i>Butylsulfinimines

    Unknown

  • Tryptophan-derived NK1 antagonists: conformationally constrained heterocyclic bioisosteres of the ester linkage.

    Richard T. Lewis;Angus M. Macleod;Kevin J. Merchant;Fintan Kelleher

  • Development of a pharmaceutical cocrystal of a monophosphate salt with phosphoric acid

    Alex M. Chen;Martha E. Ellison;Andrey Peresypkin;Robert M. Wenslow

Frequent Co-Authors

Deborah L. Zink
Deborah L. Zink Weizenbaum-Institut
Sheo B. Singh
Sheo B. Singh MSD (United States)
Gerald F. Bills
Gerald F. Bills The University of Texas Health Science Center at Houston
Raymond Baker
Raymond Baker MSD (United States)
William D. Wulff
William D. Wulff Michigan State University
Matthew J. Wyvratt
Matthew J. Wyvratt Medicines for Malaria Venture
Paul J. Reider
Paul J. Reider Princeton University
Fernando Pelaez
Fernando Pelaez Spanish National Cancer Research Centre
Margaret A. Cascieri
Margaret A. Cascieri MSD (United States)
Robert A. Reamer
Robert A. Reamer MSD (United States)

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Chemistry in the USA opens doors to a variety of career pathways beyond traditional laboratory roles. For those interested in legal aspects related to chemical compounds or patents, exploring the types of paralegals and salaries can provide insight into specialized legal support roles with competitive pay.

Alternatively, graduates with a strong understanding of drug chemistry might consider pharmaceutical sales. Understanding how much do pharmaceutical reps make can help students weigh the financial benefits of this dynamic career that blends science with business and communication skills.

For those contemplating a clinical route, it’s important to recognize the challenges involved in becoming a pharmacist. The detailed guide on is it hard to become a pharmacist offers a realistic view of the educational commitment and dedication required to enter this vital healthcare profession.

Finally, a degree in Chemistry can also lead to forensic applications. Positions like autopsy technicians play a critical role in medical examinations, and learning more about autopsy tech education, salary, and job outlook can help students decide if this niche career fits their interests.

Best Scientists Citing Richard G. Ball

Trending Scientists